Autoimmunity Link in Long COVID Patients
Researchers identified autoantibodies as a driver of long COVID symptoms in a subset of individuals, suggesting new treatment pathways.
Researchers identified autoantibodies as a driver of long COVID symptoms in a subset of individuals, suggesting new treatment pathways.
Researchers identified autoantibodies as a driver of long COVID symptoms in a subset of individuals, suggesting new treatment pathways.
Read MoreChildren with long COVID report higher levels of fatigue and sleep disturbance than those with cancer or autism.
Read MoreA clinical trial found that fluvoxamine significantly improved fatigue and quality of life for Long COVID patients with persistent symptoms.
Read MoreA two-week course of metformin or ursodeoxycholic acid (UDCA) did not meaningfully improve recovery from long COVID symptoms.
Read MoreOlder women with a history of both depression and anxiety had a 78% higher risk of developing long COVID complications after infection.
Read MoreVanderbilt Health investigators are conducting a phase 3 clinical trial of baricitinib for the treatment of persistent neurological and cardiopulmonary symptoms of long COVID.
Read MorePatients with neurocognitive difficulties post COVID-19 infection displayed a significant increase in their blood plasma of a crucial protein linked to neurodegenerative diseases and found in many Alzheimer’s patients.
Read MoreScientists identified key genetic drivers behind long COVID, revealing why some people experience symptoms long after initial infection.
Read MoreLatent or concurrent infections—especially Epstein-Barr virus and tuberculosis—may drive persistent symptoms in a subset of long COVID patients.
Read MoreAn eight-week exercise-based rehabilitation program improved immune function in patients with long COVID.
Read MoreChildren and adolescents were twice as likely to experience long COVID after catching COVID for the second time, compared to their peers with a single previous infection.
Read MoreWhat is Long COVID? Despite hundreds of published studies and millions affected worldwide, the medical field still lacks a clear answer.
Read MoreDespite the perception that COVID-19 isn’t a pediatric disease, a growing number of young children are now exhibiting symptoms of long COVID, researchers say.
Read MorePatients with financial hardship, food insecurity, less than a college education, and healthcare access challenges were at higher risk for developing long COVID.
Read MoreA new Yale study has found a promising target for treating the brain fog that can follow COVID-19 and offers new insight into a hypothesis about the origin of Alzheimer’s disease.
Read MorePhysical well-being, by contrast, returned after three months; up to 20% of patients continued experiencing suboptimal overall health-related quality of life one year after infection.
Read MorePatients suffering from long COVID may exhibit persistent inflammation in the heart and lungs for up to a year following SARS-CoV-2 infection
Read MoreUp to two years after infection, long COVID significantly increases children’s risks of chronic kidney disease, gastrointestinal issues, and cardiovascular conditions.
Read MoreCOVID-19 infection may be associated with an increase in the number of myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS) cases.
Read MoreResearchers following nearly 1,000 people with long COVID found few changes to their symptoms in the second year of illness.
Read MoreArtificial intelligence identified a molecular signature of long COVID in children’s blood with 93% accuracy, according to a recent study.
Read MoreThe investigational treatment improved lung function and quality of life in previously hospitalized COVID-19 patients with long-term pulmonary complications.
Read MoreIndividuals who have had multiple COVID-19 infections appear prone to contracting long COVID, which may include symptoms such as fatigue, respiratory distress, and mental fog.
Read MoreNew research suggests COVID-19 infection may lead to cases of a chronic condition, resembling but diagnostically separate from long COVID, characterized by persistent fatigue and post-exertional malaise.
Read More